Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia

SUMMARY: COVID-19 lockdowns have impacted management of chronic diseases such as osteoporosis. Adherence to the 6-monthly dosing schedule of denosumab, the parenteral anti-osteoporosis medication most often used in Singapore, was significantly reduced during the lockdown period compared to that duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandran, Manju, Hao, Ying, Kwee, Ann Kerwen, Cheen, Mcvin Hua Heng, Chin, Yun Ann, Ng, Valerie Yun Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379568/
https://www.ncbi.nlm.nih.gov/pubmed/34417842
http://dx.doi.org/10.1007/s00198-021-06085-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379568/
https://www.ncbi.nlm.nih.gov/pubmed/34417842
http://dx.doi.org/10.1007/s00198-021-06085-0

Ejemplares similares